Compare ADAC & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ADAC | FENC |
|---|---|---|
| Founded | 2025 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 285.2M | 230.8M |
| IPO Year | N/A | 2010 |
| Metric | ADAC | FENC |
|---|---|---|
| Price | $9.93 | $9.64 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $14.50 |
| AVG Volume (30 Days) | 35.6K | ★ 219.6K |
| Earning Date | 01-01-0001 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $44,642,000.00 |
| Revenue This Year | N/A | $65.12 |
| Revenue Next Year | N/A | $41.08 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.86 | $5.65 |
| 52 Week High | $9.99 | $9.92 |
| Indicator | ADAC | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 67.11 | 76.69 |
| Support Level | $9.91 | $7.49 |
| Resistance Level | $9.99 | $9.92 |
| Average True Range (ATR) | 0.01 | 0.57 |
| MACD | 0.00 | 0.30 |
| Stochastic Oscillator | 50.00 | 87.13 |
American Drive Acquisition Co is a blank check company.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.